AUG 18, 2020 4:18 PM PDT

Researchers Discover Mechanism to Prevent Antibiotic Resistance

WRITTEN BY: Annie Lennon

Researchers from the Monash Biomedicine Discovery Institute have discovered a method used by bacteria to develop antibiotic resistance and evade immune responses. The research may point to new ways to treat antibiotic-resistant bacterial infections.  

In the study, the researchers found that bacteria release toxins that disarm the mitochondria of immune cells. These immune cells then sense their mitochondria are no longer able to work during infection, something that then triggers apoptosis, also known as cell death. 

Ironically, first author of the study, Dr. Pankaj Deo, says that, contrary to popular belief, it is the activation of factors within the host's cell that leads to its death as opposed to the bacterial toxins themselves. To test this theory, however, the researchers then decided to target these apoptotic factors in immune cells in mouse models to see whether they could stop the process in its tracks. 

In doing so, they were able to reduce inflammation in mice, which in turn went on to improve their health outcomes. Although they focused on just three bacterial pathogens (including the deadly Pseudomonas aeruginosa, found in hospitals and is known to be resistant to multiple antibiotics), the researchers say that their findings could also be applied to other species of bacteria.

"What scientists have thought before is that when endotoxins (part of the cell wall of Gram-negative bacteria) are released by bacteria, they induce an inflammatory type of programmed cell death called pyroptosis in immune cells." says Dr. Deo. 

"We've found that the pathogenic bacteria use a similar mechanism to release additional toxins. They kill immune cells by releasing small surface structures called outer membrane vesicles—packages of toxins that target mitochondria. The mitochondria are disarmed, become dysfunctional then die according to apoptosis or cellular suicide."

The researchers now aim to investigate the potential of existing drugs that target the apoptotic response to see if they can be repurposed for bacterial infections. 

 

Sources: PhysNature 

 

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
AUG 25, 2020
Cannabis Sciences
FDA Approves Cannabis Drug to Treat Rare Genetic Disease
AUG 25, 2020
FDA Approves Cannabis Drug to Treat Rare Genetic Disease
The US Food and Drug Administration has approved Epidiolex, a cannabidiol (CBD) oral solution, to treat seizures linked ...
SEP 17, 2020
Immunology
COVID Vaccine Works in Macaques - What about in Humans?
SEP 17, 2020
COVID Vaccine Works in Macaques - What about in Humans?
Pharmaceutical giant Pfizer, in partnership with BioNTech has reported that one of its lead vaccine candidates has shown ...
SEP 22, 2020
Drug Discovery & Development
New Treatment for Mouth-Hand-Foot Disease
SEP 22, 2020
New Treatment for Mouth-Hand-Foot Disease
A study appearing next week in the journal Nature Communications offers some good news in the search for antiviral drugs ...
SEP 27, 2020
Cell & Molecular Biology
How Spiders May Open a Path to IBS Treatment
SEP 27, 2020
How Spiders May Open a Path to IBS Treatment
Irritable bowel syndrome (IBS) is term that describes a gut disorder that causes abdominal pain, cramping, diarrhea or c ...
OCT 15, 2020
Cannabis Sciences
Can Cannabis Treat Traumatic Brain Injury?
OCT 15, 2020
Can Cannabis Treat Traumatic Brain Injury?
Traumatic brain injury (TBI) happens when the head is violently hit by an object or when an object pierces the skull and ...
OCT 21, 2020
Drug Discovery & Development
New ALS Treatment Extends Life for Several Months
OCT 21, 2020
New ALS Treatment Extends Life for Several Months
Currently, there are only two approved medications to treat Lou Gehrig's disease (also known as ALS), a condition po ...
Loading Comments...